TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: HIV Pre-Exposure Prophylaxis (PrEP) uptake and persistence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Hepatitis C Virus (HCV) care uptake and persistence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Medications for opioid use disorder (MOUD) uptake and persistence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Participation in a telehealth program
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Local Sweat Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy after CM336 treatment at week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Predictive risk model for high-risk colorectal neoplasm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Fertility Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Scores of OSCE stations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concordance between CSS-Clinician and CSS-SR total scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Urinary Symptom Changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Incidence of Postoperative Pulmonary Complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Psychotropic medication initiation or change
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Readmissions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: PSA50 Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of eGRF equation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Detection of deafness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Myasthenia Gravis Activities of Daily Living (MG-ADL)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Validation of extracellular vesicles as biomarker
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Follicular and luteal phase oocytes Magenta score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: AUC from time 0 to last collection time t (AUC0-t)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum concentration in plasma (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative Reinforcing Value (RRV) of food
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Invasive Breast Cancer-Free Survival (iBCFS)
Endpoint domain: Mortality/survival
Primary endpoint: Changes in CD4 T cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes in CD8 T cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Infant growth velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Serious Adverse Events Over 52 Weeks Post-Vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Presence of a time-intensity curve (TIC) of contrast agent
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of signal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: brain blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Content validity of the Non-Ambulatory Hip Pain questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Internal reliability of the Non-Ambulatory Hip Pain questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Initiation of buprenorphine maintenance without precipitated withdrawal
Endpoint domain: Adverse events/effects
Primary endpoint: Change From Baseline in Corneal Staining Scores at Week 4
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax for LNG and EE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUCinf for LNG and EE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUClast for LNG and EE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of ventilator settings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Characterization of Safety
Endpoint domain: Adverse events/effects
Primary endpoint: One-year probability of GRFS
Endpoint domain: Mortality/survival
Primary endpoint: Level of anxiety before surgery
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of participants reporting immediate adverse events/adverse drug reactions (AEs/ADRs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants reporting serious adverse events/adverse drug reactions (SAEs/SADRs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants reporting solicited injection site and systemic reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants reporting unsolicited non-serious AEs/ADRs
Endpoint domain: Adverse events/effects
Primary endpoint: acute grade 3/4 lymphopenia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Uncomplicated initial treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Explosive muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Jump ability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of antibiotics change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: ARC3 Consent Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Illinois Rape Myth Acceptance Scale-Short Form
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Attitudes Towards Dating Violence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Dating Behavior Survey
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Coping Responses to Sexual Aggression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Barriers to Resistance
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Knowledge and Use of Resources
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Perioperative Thirst Discomfort Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Improvement in Ocular Surface Disease Index (OSDI) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grade 3-4 Non-hematologic Rate
Endpoint domain: Adverse events/effects
Primary endpoint: Grade 3-4 hematologic Rate
Endpoint domain: Adverse events/effects
Primary endpoint: Permanent aneurysm occlusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: volume reduction ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants with Clinical Remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration-time Curve From Time 0 to Infinity (AUCinf) for Bosutinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Observed Plasma Concentration (Cmax) for Bosutinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of remote monitoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hypertonic index of the pelvic muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skin assessment of the lower limb
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Venous Clinical Severity Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Area Under the Plasma Concentration-time Curve (AUC) from Time Zero to the Last Quantifiable Concentration (AUClast)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC from Time Zero Extrapolated to Infinity (AUCinf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Annualized Bleeding Rates (ABR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of Participants with Device and/or Procedure Related Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: FES-I Fall efficacy scale international
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Dizziness Handicap inventory
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pectoralis major cross sectional area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Quadriceps femoris cross sectional area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Quadriceps femoris muscular thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Pectoralis major muscular thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Overall change in bothering pelvic floor symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: C. Diff Decolonization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change from Baseline in DAS28 (CRP) at Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Postural deviation on head and neck
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proton density fat fraction in hepatic steatosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: International Prostate Symptom Score (IPSS) total Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Voiding function in uroflowmetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cured of T. trichiura infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Incidence Rate Ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Foot posture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Stroke recovery enhancement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Soft tissue dehiscence reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Safety Measures
Endpoint domain: Adverse events/effects
Primary endpoint: Change in viral load in nasopharyngeal samples for adult patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in viral load in nasopharyngeal samples for pediatric patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Isthmocele evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Six min walking distances
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The number of weeks during the 24 week follow-up period with no illicit opioid use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in QTc during drug administration session
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in regional myocardial function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Myocardial stunning
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cmax of aceclofenac in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-t of aceclofenac in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of enrollment in clinical study
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of patients remaining in clinical trial until completion
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Eating Disorder Inventory-3 (EDI-3)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Physical Appearance State and Trait Anxiety Scale (PASTAS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cardiovascular Endurance through the six-minute walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Processing Speed and Executive Function through the Oral Symbol Digits Test (NIH Toolbox)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: etiologic diagnosis identification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: incidence of SAN dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: incidence of AVN dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of time of glucose levels spent in the target range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Plasma concentration-time profile over 24 hours (AUC) of key metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximal volume consumption of oxygen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximal velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of plasma cells specific for HPV16/18 VLPs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Timed Up and Go Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Capabilities of Upper Extremities Questionnaire (CUE-Q)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Percentage of patients completing the study per-protocol
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Changes in cross-sectional area airway opening
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Changes in airflow outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Prevalence of problematic use of social media
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Post-test Cortisol Awakening Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: NRI-SS (Nutraceuticals Research Institute's Stress Scale)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 12-month Overall Survival rate (OS rate)
Endpoint domain: Mortality/survival
Primary endpoint: Percent change in focal onset seizure frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence, relatedness, seriousness and severity of adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Prostate cancer down-staging
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: ED Visit
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Fatigue and Cognition
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Perceived Cognition
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Perceptual Fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Mean ESAS-r composite scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in movement time (s) of trained pattern
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in dual task effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in brain activity during performance of trained pattern
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Solicited injection site and systemic AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Unsolicited injection site and systemic AEs
Endpoint domain: Adverse events/effects
Primary endpoint: All SAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Abnormalities on different parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of CUAL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: changes in overhydration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in Modified Mayo Clinical Score (MMCS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Proportion of alerted encounters with CDS engagement
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Histologic improvements in NAFLD Activity Score (NAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of seroconversion for RVFV neutralizing antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in healthy lifestyle behaviors score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in health fatalism score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in cardiovascular disease risk knowledge level score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Incidence of complications related to artificial abortion
Endpoint domain: Adverse events/effects
Primary endpoint: tibial cartilage volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Completion of all therapy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Biochemical Parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Demand for the treatment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Adherence
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Acceptability by participants
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Post obturation pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in Functional Ability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: VGPR Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Visual image quality score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration-time curve (AUC) from time 0 to dose interval (AUCτ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oral Tolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants who received lenacapavir injection
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: 30-Day Continuous Abstinence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Observer-rated shared decision making
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Rate of Falls
Endpoint domain: Adverse events/effects
Primary endpoint: Sedentary time
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Patient-reported HRQOL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Maximum change in total score of the Physician Withdrawal Checklist (PWC-20)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: development of white spot lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Tilt of IOL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decentration of IOL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PrEP uptake
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Retention into PrEP
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Inferior vena cava variability index (IVCv)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Iron Status Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cognitive Function Assessment
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Variation of total body weight from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of atrial fibrillation paroxysms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Perceived stress (T1)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perceived Stress (T2)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Periodontal pocket depth measuring
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes